-
1 Comment
Medicalgorithmics S.A. is currently in a long term uptrend where the price is trading 27.0% above its 200 day moving average.
Medicalgorithmics S.A.'s total revenue sank by 40.5% to $25M since the same quarter in the previous year.
Its net income has dropped by 4405.0% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 88.8% to $1M since the same quarter in the previous year.
Based on the above factors, Medicalgorithmics S.A. gets an overall score of 1/5.
| Exchange | WAR |
|---|---|
| CurrencyCode | PLN |
| ISIN | PLMDCLG00015 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Target Price | 44.55 |
|---|---|
| Beta | 0.76 |
| Market Cap | 327M |
| PE Ratio | None |
| Dividend Yield | None |
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythm Platform, a hardware-agnostic cloud-based software that leverages cutting-edge AI technology to detect, classify, analyze, and report ECG data; and DeepRhythmAI, a set of algorithms for heart rhythm analysis that integrates into third-party software and devices. The company also provides virtual cardiac stress test (VCAST), an AI-based medical system developed for non-invasive, clinical quantitative, and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. In addition, it operates ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal based on deep learning methods. In addition, the company engages in the provision of information technology and ECG monitoring services; research and development, including the development of artificial intelligence (AI) algorithms and software for arrhythmia diagnostics, as well as the development and commercialization of AI-based VCAST cardiac imaging technology; and production of electromedical equipment. Medicalgorithmics S.A. company was incorporated in 2005 and is headquartered in Warsaw, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MDG.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
